jerryyangpoker| U.S. stocks change| BioNTech rose more than 6% to show important clinical trial updates at ASCO Annual Meeting
Politics
2024-05-22 23:03 39
editor
German pharmaceutical company BioNTech(BNTXjerryyangpoker.US) continued to rise, rising 6.36% to US$97.9. On the news front. BioNTech will present important presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetingjerryyangpokeris updated to demonstrate progress in its multiple immuno-oncology product lines, including innovative treatments for a variety of cancers. The company's ambitious goal is to launch its first cancer immunotherapy by 2026 and gain approval for 10 cancer indications by 2030, a promising development for patients and investors.
Prev
baccaratfr| Palleton's intraday changes rose sharply by 6.06% in early trading
Nextbestvideopoker| China United Development Holdings (00264.HK) plans to discount approximately 19.05% and place up to 30 million shares with a net raise of HK$24.7 million
Related articles
Message